Sales rise 20.38% to Rs 2001.98 crore
Net profit of Emcure Pharmaceuticals rose 39.83% to Rs 194.57 crore in the quarter ended September 2024 as against Rs 139.15 crore during the previous quarter ended September 2023. Sales rose 20.38% to Rs 2001.98 crore in the quarter ended September 2024 as against Rs 1663.09 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales2001.981663.09 20 OPM %19.0319.78 -PBDT370.31271.43 36 PBT273.41201.16 36 NP194.57139.15 40Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content